I was suprised to see reports that Congress doesn’t see a way to stop 5,000 percent hikes in price for a medicine.

A new law isn’t needed. Anti-trust laws have been used to force companies to give up purchased assets that were being used to allow monopolistic pricing.

This would seem to be a classic example. The argument against squeezing the profits of a company that makes investments, and risks loss to develop new medicines, do not apply at all to a case like this.

Tom Heyns


Only subscribers are eligible to post comments. Please subscribe or to participate in the conversation. Here’s why.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.